https://assets.capyfin.com/instruments/678fdc13234e27009c5d5824.png avatar
Cigna
🇺🇸 NYSE:CI
View Company
OverviewEarningsDividends
•
Mar 31, 2023

Cigna Q1 2023 Earnings Report

The Cigna Group reported strong first quarter 2023 results, reflecting growth and focused execution across its diversified portfolio of businesses.

Key Takeaways

The Cigna Group reported strong first-quarter results, with shareholders’ net income reaching $1.3 billion, or $4.24 per share. Adjusted income from operations was $1.6 billion, or $5.41 per share.

The Cigna Group's adjusted income from operations for first quarter 2023 was $1.6 billion.

Shareholders’ net income for first quarter 2023 was $1.3 billion, or $4.24 per share.

The Cigna Group's outlook for full year 2023 adjusted revenues increased to at least $188.0 billion.

The Cigna Group’s outlook for full year 2023 consolidated adjusted income from operations increased to at least $7.36 billion, or at least $24.70 per share.

Total Revenue
$46.5B
Previous year: $44.1B
+5.5%
EPS
$5.41
Previous year: $6.01
-10.0%
Gross Profit
$0
0
Cash and Equivalents
$7.94B
Previous year: $4.42B
+79.4%
Total Assets
$148B
Previous year: $153B
-3.0%

Cigna

Cigna

Forward Guidance

The Cigna Group's outlook for full year 2023 adjusted revenues increased to at least $188.0 billion. The Cigna Group’s outlook for full year 2023 consolidated adjusted income from operations increased to at least $7.36 billion, or at least $24.70 per share.

Positive Outlook

  • Full year 2023 adjusted revenues increased to at least $188.0 billion.
  • Full year 2023 consolidated adjusted income from operations increased to at least $7.36 billion.
  • Full year 2023 consolidated adjusted income from operations increased to at least $24.70 per share
  • Outlook includes the impact of expected future share repurchases
  • Outlook includes anticipated 2023 dividends

Challenges Ahead

  • Actual results may differ materially depending on a number of factors.
  • The Company’s outlook excludes the potential effects of any other business combinations that may occur after the date of this earnings release.
  • The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital.
  • The share repurchase program may be effected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including through Rule 10b5-1 trading plans, or privately negotiated transactions.
  • The program may be suspended or discontinued at any time.

Company Overview

Full financial data and analysis

View Cigna